Contract Drug Research Company QPS Hosts Delegation From Taiwan
Journalist: Delaware Business Now!
Publication: Delaware Business Now!
Clinical trials in the UK are reportedly declining as the country grapples with Brexit – a change which could make access to preclinical and bioanalytical research materials, including NHPs, problematic, says QPS
Journalist: Melissa Fassbender, US Editor
Publication: Outsourcing-Pharma.com
QPS Expands Translational Medicine Unit Three-Fold to Increase Support for Biopharmaceutical, Biotechnology and cRO Partners, Address Market Demand for Gene Therapy
Journalist: Pam George
Publication: Innovation Delaware, an annual publication
QPS is expanding ‘aggressively’ at its US-based headquarters, rebuilding on a rolling basis to support a growing demand for gene therapy treatments, says VP
Journalist: Melissa Fassbender, US Editor
Publication: Outsourcing-Pharma.com
QPS Announces Launch of New Brand Identity, Celebrates 24 Years of Growth
Journalist: Kate Anderton, B.Sc., Editor
Publication: News-medical.net
QPS has expanded its Phase I clinical trial capabilities by more than 20% and doubled its lab space, which will allow the CRO to accommodate ‘exponentially more sponsors’ as demand continues to increase.
Journalist: Melissa Fassbender, US Editor
Publication: Outsourcing-Pharma.com
